Enhanced thrombin generation and reduced intact protein S in processed solvent detergent plasma

被引:17
作者
Pitkanen, Hanna [1 ]
Jouppila, Annukka [1 ]
Mowinckel, Marie-Christine [2 ,3 ]
Lemponen, Marja [4 ,5 ,6 ]
Patiwael, Sanne [7 ]
Sandset, Per Morten [2 ,3 ]
Lassila, Riitta [4 ,5 ,6 ]
Brinkman, Herm Jan M. [7 ]
机构
[1] Univ Helsinki, Cent Hosp, Res Inst, Helsinki, Finland
[2] Oslo Univ Hosp, Dept Hematol, Oslo, Norway
[3] Univ Oslo, Inst Clin Med, Oslo, Norway
[4] Univ Helsinki, HUSLAB, Ctr Canc, Coagulat Disorder Unit, Helsinki, Finland
[5] Univ Helsinki, Lab Serv HUSLAB, Helsinki, Finland
[6] Univ Helsinki, Cent Hosp, Helsinki, Finland
[7] Sanquin Res, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands
关键词
Plasma transfusion; S/D-treated plasma; Protein S; Thrombin generation; Fibrinolysis; SOLVENT/DETERGENT-TREATED PLASMA; FACTOR PATHWAY INHIBITOR; FRESH-FROZEN PLASMA; LIVER-TRANSPLANTATION; ANTICOAGULANT ACTIVITY; FACTOR-XA; FIBRINOLYSIS; COAGULOPATHY; REDUCTION; BINDING;
D O I
10.1016/j.thromres.2014.10.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Standardized solvent/detergent (S/D)-treated plasma has been developed as an improved alternative to fresh frozen-plasma (FFP) in the management of severe bleeds. This study aimed at exploring compositional modifications that may influence the general applicability of S/D-treated plasma. Materials and methods: S/D-treated plasma and FFP were compared in procoagulant microparticles and concentration of coagulation factors and inhibitors. Compositional differences were correlated with hemostatic and fibrinolytic characteristics as measured by PT, APTT, thrombin generation and thromboelastography. Results: Procoagulant microparticles were absent in S/D-treated plasma. Procoagulant factors were within the normal range. Antithrombin, TFPI and protein S antigen may be normal or slightly reduced depending on the duration of the S/D-treatment, but S/D-treated plasmas had only 12-14% intact functional protein S. Thrombin generation was subsequently increased, especially at low tissue factor concentration (1 pM). Plasma coagulation times in PT and APTT were normal, but 1.5-fold reduced in thromboelastography at low TF (1 pM). alpha 2-antiplasmin was reduced with a concomitant 3-4 fold shortened clot lysis time measured by thromboelastography in the presence of TF (10 pM) and tissue-type plasminogen activator (0.2 mu g/ml). Enhanced fibrin degradation could be normalised with tranexamic acid. Conclusions: S/D-treatment seems to induce a procoagulant phenotype that results from a strongly reduced level of intact single chain protein S. Whether this may correct the apparent hemostatic imbalance as suggested from the increased fibrinolysis remains to be established. Our findings may bear implications in patients with deficiencies of natural anticoagulants. Co-administration of tranexamic acid appears beneficial to control enhanced fibrinolysis. (C) 2014 Elsevier Ltd. All rights reserved .
引用
收藏
页码:167 / 174
页数:8
相关论文
共 23 条
  • [1] Bertolini J., 2013, Production of Plasma Proteins for Therapeutic Use, V1a
  • [2] Proteolytic cleavage of protein S during the hemostatic response
    Brinkman, HJM
    Mertens, K
    Van Mourik, JA
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (12) : 2712 - 2720
  • [3] Advances in understanding pathogenic mechanisms of thrombophilic disorders
    Dahlback, Bjorn
    [J]. BLOOD, 2008, 112 (01) : 19 - 27
  • [4] Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis
    Dahm, A
    Vlieg, AV
    Bendz, B
    Rosendaal, F
    Bertina, RM
    Sandset, PM
    [J]. BLOOD, 2003, 101 (11) : 4387 - 4392
  • [5] Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism
    Dashty, Monireh
    Motazacker, Mohammad M.
    Levels, Johannes
    de Vries, Marcel
    Mahmoudi, Morteza
    Peppelenbosch, Maikel P.
    Rezaee, Farhad
    [J]. THROMBOSIS AND HAEMOSTASIS, 2014, 111 (03) : 518 - 530
  • [6] Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP®)
    de Jonge, J
    Groenland, THN
    Metselaar, HJ
    Ijzermans, JNM
    van Vliet, HHDM
    Visser, L
    Tilanus, HW
    [J]. ANESTHESIA AND ANALGESIA, 2002, 94 (05) : 1127 - 1131
  • [7] Platelet-mediated proteolytic down regulation of the anticoagulant activity of protein S in individuals with haematological malignancies
    Dienava-Verdoold, Ilze
    Marchetti, Marina R.
    Boome, Liane C. J. Te
    Russo, Laura
    Falanga, Anna
    Koene, Harry R.
    Mertens, Koen
    Brinkman, Herm Jan M.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2012, 107 (03) : 468 - 476
  • [8] Food and Drug Administration, 2013, OCT POOL PLASM HUM S
  • [9] Protein S as Cofactor for TFPI
    Hackeng, Tilman M.
    Rosing, Jan
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (12) : 2015 - 2020
  • [10] Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery
    Haubelt, H
    Blome, M
    Kiessling, AH
    Isgro, F
    Bach, J
    Saggau, W
    Hellstern, P
    [J]. VOX SANGUINIS, 2002, 82 (01) : 9 - 14